Form 8-K - Current report:
SEC Accession No. 0001837607-24-000085
Filing Date
2024-10-07
Accepted
2024-10-07 17:01:10
Documents
40
Period of Report
2024-10-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aeon-20241007x8k.htm   iXBRL 8-K 41611
2 EX-99 aeon-20241007xex99.htm EX-99 44010
3 GRAPHIC aeon-20241007xex99g001.jpg GRAPHIC 66898
4 GRAPHIC aeon-20241007xex99g002.jpg GRAPHIC 338816
5 GRAPHIC aeon-20241007xex99g003.jpg GRAPHIC 166890
6 GRAPHIC aeon-20241007xex99g004.jpg GRAPHIC 184745
7 GRAPHIC aeon-20241007xex99g005.jpg GRAPHIC 141886
8 GRAPHIC aeon-20241007xex99g006.jpg GRAPHIC 156015
9 GRAPHIC aeon-20241007xex99g007.jpg GRAPHIC 124460
10 GRAPHIC aeon-20241007xex99g008.jpg GRAPHIC 151955
11 GRAPHIC aeon-20241007xex99g009.jpg GRAPHIC 100012
12 GRAPHIC aeon-20241007xex99g010.jpg GRAPHIC 155418
13 GRAPHIC aeon-20241007xex99g011.jpg GRAPHIC 142441
14 GRAPHIC aeon-20241007xex99g012.jpg GRAPHIC 191890
15 GRAPHIC aeon-20241007xex99g013.jpg GRAPHIC 112322
16 GRAPHIC aeon-20241007xex99g014.jpg GRAPHIC 129290
17 GRAPHIC aeon-20241007xex99g015.jpg GRAPHIC 128626
18 GRAPHIC aeon-20241007xex99g016.jpg GRAPHIC 137539
19 GRAPHIC aeon-20241007xex99g017.jpg GRAPHIC 147934
20 GRAPHIC aeon-20241007xex99g018.jpg GRAPHIC 112275
21 GRAPHIC aeon-20241007xex99g019.jpg GRAPHIC 90189
22 GRAPHIC aeon-20241007xex99g020.jpg GRAPHIC 154487
23 GRAPHIC aeon-20241007xex99g021.jpg GRAPHIC 119611
24 GRAPHIC aeon-20241007xex99g022.jpg GRAPHIC 108875
25 GRAPHIC aeon-20241007xex99g023.jpg GRAPHIC 138836
26 GRAPHIC aeon-20241007xex99g024.jpg GRAPHIC 134624
27 GRAPHIC aeon-20241007xex99g025.jpg GRAPHIC 53482
  Complete submission text file 0001837607-24-000085.txt   5012343

Data Files

Seq Description Document Type Size
28 EX-101.SCH aeon-20241007.xsd EX-101.SCH 4044
29 EX-101.DEF aeon-20241007_def.xml EX-101.DEF 2869
30 EX-101.LAB aeon-20241007_lab.xml EX-101.LAB 17853
31 EX-101.PRE aeon-20241007_pre.xml EX-101.PRE 10675
42 EXTRACTED XBRL INSTANCE DOCUMENT aeon-20241007x8k_htm.xml XML 5053
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 241358443
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)